US Stock MarketDetailed Quotes

NDRA ENDRA Life Sciences

Watchlist
  • 5.0500
  • -0.2200-4.17%
Trading Nov 22 10:08 ET
2.71MMarket Cap-28P/E (TTM)

ENDRA Life Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
36.23%-1.66M
8.17%-2.08M
14.46%-2.14M
25.22%-9.55M
29.60%-2.17M
19.96%-2.6M
31.98%-2.27M
19.10%-2.51M
-14.81%-12.77M
-16.43%-3.09M
Net income from continuing operations
24.08%-2.35M
12.83%-2.23M
5.68%-2.78M
23.67%-10.06M
55.63%-1.46M
9.87%-3.1M
28.79%-2.56M
-2.96%-2.94M
-17.34%-13.18M
-5.96%-3.29M
Depreciation and amortization
-23.34%54.01K
-31.07%50.12K
-21.63%55.68K
17.58%275.45K
-9.62%61.25K
20.24%70.45K
30.59%72.71K
36.05%71.04K
4.39%234.26K
26.27%67.77K
Change In working capital
-229.07%-230.91K
217.87%47.18K
-16.39%106.67K
9.99%-923.32K
-648.17%-1.19M
202.59%178.89K
63.92%-40.03K
121.94%127.58K
18.68%-1.03M
-580.19%-159.02K
-Change in inventory
--0
719.48%138.05K
-155.75%-231.79K
91.46%-116.19K
69.20%-3.28K
--0
94.99%-22.28K
85.96%-90.63K
-95.72%-1.36M
-104.95%-10.64K
-Change in prepaid assets
309.15%353.87K
-0.46%-176.92K
-67.72%42.61K
-52.87%167.36K
258.98%124.98K
208.93%86.49K
-177.74%-176.11K
-53.94%132K
137.10%355.13K
53.97%-78.61K
-Change in payables and accrued expense
-513.44%-540.78K
-34.14%128.97K
175.15%337.71K
-836.96%-822.26K
-3,524.36%-1.27M
-33.85%130.8K
40.34%195.81K
164.40%122.74K
-77.28%111.58K
6.92%-35.09K
-Change in other current liabilities
-14.58%-43.99K
-14.58%-42.91K
-14.58%-41.86K
-15.04%-152.23K
-14.91%-39.85K
-15.08%-38.39K
-15.09%-37.45K
-15.08%-36.53K
-31.88%-132.33K
-15.42%-34.68K
Cash from discontinued investing activities
Operating cash flow
36.23%-1.66M
8.17%-2.08M
14.46%-2.14M
25.22%-9.55M
29.60%-2.17M
19.96%-2.6M
31.98%-2.27M
19.10%-2.51M
-14.81%-12.77M
-16.43%-3.09M
Investing cash flow
Cash flow from continuing investing activities
0
11K
11.87%-23.8K
87.80%-24.72K
105.91%2.28K
0
0
69.78%-27K
-350.17%-202.58K
-38.56K
Net PPE purchase and sale
--0
--11K
11.87%-23.8K
87.80%-24.72K
105.91%2.28K
--0
--0
69.78%-27K
-350.17%-202.58K
---38.56K
Cash from discontinued investing activities
Investing cash flow
--0
--11K
11.87%-23.8K
87.80%-24.72K
105.91%2.28K
--0
--0
69.78%-27K
-350.17%-202.58K
---38.56K
Financing cash flow
Cash flow from continuing financing activities
-99.85%1.68K
55.05%7.34M
468.9K
-10.49%7.52M
1.67M
1.11M
-37.28%4.73M
0
-37.32%8.4M
0
Net issuance payments of debt
--0
--0
---28.48K
----
----
----
--0
--0
----
----
Net common stock issuance
--0
-84.54%728.5K
--419.97K
-22.81%6.48M
--656.81K
--1.11M
-37.54%4.71M
--0
-20.88%8.4M
--0
Proceeds from stock option exercised by employees
--1.68K
32,861.80%6.61M
--77.42K
--1.03M
--1.01M
--0
--20.05K
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
-99.85%1.68K
55.05%7.34M
--468.9K
-10.49%7.52M
--1.67M
--1.11M
-37.28%4.73M
--0
-37.32%8.4M
--0
Net cash flow
Beginning cash position
32.81%6.4M
-51.82%1.13M
-42.04%2.83M
-48.33%4.89M
-58.40%3.33M
-57.27%4.82M
-66.95%2.36M
-48.33%4.89M
30.91%9.46M
-32.03%8.02M
Current changes in cash
-11.49%-1.66M
113.70%5.27M
32.94%-1.7M
55.05%-2.06M
83.99%-500.63K
54.47%-1.48M
-40.63%2.46M
-8.55%-2.53M
-304.65%-4.57M
-34.12%-3.13M
End cash Position
42.30%4.75M
32.81%6.4M
-51.82%1.13M
-42.04%2.83M
-42.04%2.83M
-58.40%3.33M
-57.27%4.82M
-66.95%2.36M
-48.33%4.89M
-48.33%4.89M
Free cash flow
36.23%-1.66M
8.65%-2.07M
14.31%-2.17M
26.13%-9.58M
30.24%-2.18M
20.32%-2.6M
33.17%-2.27M
20.52%-2.53M
-16.16%-12.97M
-17.89%-3.13M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 36.23%-1.66M8.17%-2.08M14.46%-2.14M25.22%-9.55M29.60%-2.17M19.96%-2.6M31.98%-2.27M19.10%-2.51M-14.81%-12.77M-16.43%-3.09M
Net income from continuing operations 24.08%-2.35M12.83%-2.23M5.68%-2.78M23.67%-10.06M55.63%-1.46M9.87%-3.1M28.79%-2.56M-2.96%-2.94M-17.34%-13.18M-5.96%-3.29M
Depreciation and amortization -23.34%54.01K-31.07%50.12K-21.63%55.68K17.58%275.45K-9.62%61.25K20.24%70.45K30.59%72.71K36.05%71.04K4.39%234.26K26.27%67.77K
Change In working capital -229.07%-230.91K217.87%47.18K-16.39%106.67K9.99%-923.32K-648.17%-1.19M202.59%178.89K63.92%-40.03K121.94%127.58K18.68%-1.03M-580.19%-159.02K
-Change in inventory --0719.48%138.05K-155.75%-231.79K91.46%-116.19K69.20%-3.28K--094.99%-22.28K85.96%-90.63K-95.72%-1.36M-104.95%-10.64K
-Change in prepaid assets 309.15%353.87K-0.46%-176.92K-67.72%42.61K-52.87%167.36K258.98%124.98K208.93%86.49K-177.74%-176.11K-53.94%132K137.10%355.13K53.97%-78.61K
-Change in payables and accrued expense -513.44%-540.78K-34.14%128.97K175.15%337.71K-836.96%-822.26K-3,524.36%-1.27M-33.85%130.8K40.34%195.81K164.40%122.74K-77.28%111.58K6.92%-35.09K
-Change in other current liabilities -14.58%-43.99K-14.58%-42.91K-14.58%-41.86K-15.04%-152.23K-14.91%-39.85K-15.08%-38.39K-15.09%-37.45K-15.08%-36.53K-31.88%-132.33K-15.42%-34.68K
Cash from discontinued investing activities
Operating cash flow 36.23%-1.66M8.17%-2.08M14.46%-2.14M25.22%-9.55M29.60%-2.17M19.96%-2.6M31.98%-2.27M19.10%-2.51M-14.81%-12.77M-16.43%-3.09M
Investing cash flow
Cash flow from continuing investing activities 011K11.87%-23.8K87.80%-24.72K105.91%2.28K0069.78%-27K-350.17%-202.58K-38.56K
Net PPE purchase and sale --0--11K11.87%-23.8K87.80%-24.72K105.91%2.28K--0--069.78%-27K-350.17%-202.58K---38.56K
Cash from discontinued investing activities
Investing cash flow --0--11K11.87%-23.8K87.80%-24.72K105.91%2.28K--0--069.78%-27K-350.17%-202.58K---38.56K
Financing cash flow
Cash flow from continuing financing activities -99.85%1.68K55.05%7.34M468.9K-10.49%7.52M1.67M1.11M-37.28%4.73M0-37.32%8.4M0
Net issuance payments of debt --0--0---28.48K--------------0--0--------
Net common stock issuance --0-84.54%728.5K--419.97K-22.81%6.48M--656.81K--1.11M-37.54%4.71M--0-20.88%8.4M--0
Proceeds from stock option exercised by employees --1.68K32,861.80%6.61M--77.42K--1.03M--1.01M--0--20.05K--0--0--0
Cash from discontinued financing activities
Financing cash flow -99.85%1.68K55.05%7.34M--468.9K-10.49%7.52M--1.67M--1.11M-37.28%4.73M--0-37.32%8.4M--0
Net cash flow
Beginning cash position 32.81%6.4M-51.82%1.13M-42.04%2.83M-48.33%4.89M-58.40%3.33M-57.27%4.82M-66.95%2.36M-48.33%4.89M30.91%9.46M-32.03%8.02M
Current changes in cash -11.49%-1.66M113.70%5.27M32.94%-1.7M55.05%-2.06M83.99%-500.63K54.47%-1.48M-40.63%2.46M-8.55%-2.53M-304.65%-4.57M-34.12%-3.13M
End cash Position 42.30%4.75M32.81%6.4M-51.82%1.13M-42.04%2.83M-42.04%2.83M-58.40%3.33M-57.27%4.82M-66.95%2.36M-48.33%4.89M-48.33%4.89M
Free cash flow 36.23%-1.66M8.65%-2.07M14.31%-2.17M26.13%-9.58M30.24%-2.18M20.32%-2.6M33.17%-2.27M20.52%-2.53M-16.16%-12.97M-17.89%-3.13M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data